FNAM (FNAM) Stock Price & Analysis
FNAM (FNAM) rose 0.00% to USD 0 as of June 10, 2026 at 09:33 UTC, according to Nexqual real-time market data.
FNAM last closed at USD 0; the session ranged USD 0.45–0.45 on volume of 300 shares. Market capitalization is $1,331, with a 52-week range of USD 0–0.45 (PNK). Source: Nexqual, June 10, 2026 at 09:33 UTC.
Key Statistics (as of June 10, 2026 at 09:33 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.45 |
| Day Range | USD 0.45 – 0.45 |
| 52-Week Range | USD 0 – 0.45 |
| Volume | 300 shares |
| Market Cap | $1,331 |
| Exchange | PNK |
Technical Analysis (FNAM)
Nexqual's technical model rates FNAM "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 09:33 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (FNAM)
Wall Street analysts rate FNAM "None", per Nexqual as of June 10, 2026 at 09:33 UTC.
| Consensus Rating | None |
|---|
Earnings (FNAM)
Source: Nexqual, June 10, 2026 at 09:33 UTC.
Financials & Fundamentals (FNAM)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 3.92 |
| Total Cash | $577,066 |
| Total Debt | $3.74M |
| Free Cash Flow | $35,081 |
Source: Nexqual, June 10, 2026 at 09:33 UTC.
Financial Health Score (FNAM)
Nexqual rates FNAM's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 09:33 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $577K cash vs $4M debt |
| Cash Flow | Weak — Operating cash flow -$641K |
| Efficiency | Mixed — No data |
Ownership (FNAM)
| Insider Ownership | +32.65% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 6.66M |
| Float | 4.48M |
Source: Nexqual, June 10, 2026 at 09:33 UTC.
Leadership (FNAM)
FNAM is led by Steve B. Warnecke (age 68), Chairman, CEO, President & CFO, per Nexqual as of June 10, 2026 at 09:33 UTC.
| Chairman, CEO, President & CFO | Steve B. Warnecke (age 68) |
|---|---|
| Founder, CTO, Treasurer & Secretary | Walter Messier (age 69) |
| Founder & Director | Virginia Orndorff (age 74) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HTGMQ | HTG Molecular Diagnostics, Inc. | USD 0 | ▲ 0% |
| EAWD | Energy and Water Development Co | USD 0.01 | ▲ 0% |
| VENZF | Venzee Technologies Inc. | USD 0.05 | ▼ 16.06% |
| BNKL | BIONIK LABORATORIES CORP | USD 0 | ▲ 0% |
| CUAUF | C3 METALS INC. | USD 0.57 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:33 UTC. This page is informational and not investment advice.